


Searching News Database: methicillin resistant Staphylococcus aureus
HSMN NewsFeed - 19 Jun 2012
MAQUET Cardiovascular Receives CE Mark For INTERGARD SYNERGY Vascular Graft
MAQUET Cardiovascular Receives CE Mark For INTERGARD SYNERGY Vascular Graft
HSMN NewsFeed - 17 Nov 2010
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
HSMN NewsFeed - 27 Mar 2009
Nabriva Therapeutics Appoints Dr David Chiswell as Chief Executive Officer
Nabriva Therapeutics Appoints Dr David Chiswell as Chief Executive Officer
HSMN NewsFeed - 27 Feb 2009
Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology
Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology
HSMN NewsFeed - 9 Sep 2008
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
HSMN NewsFeed - 31 Mar 2008
TyRx Pharma, Inc. Announces the Appointment of Gary Young, PharmD, MBA as Vice President, Marketing
TyRx Pharma, Inc. Announces the Appointment of Gary Young, PharmD, MBA as Vice President, Marketing
HSMN NewsFeed - 29 Jan 2008
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
HSMN NewsFeed - 30 Jul 2007
Elusys Appoints New Chairman of the Board and a Vice President of Development
Elusys Appoints New Chairman of the Board and a Vice President of Development
HSMN NewsFeed - 15 May 2007
Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing
Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing
HSMN NewsFeed - 17 Jan 2007
Cepheid and bioMerieux Enter Into Strategic Agreements to Develop and Market Sepsis and MRSA Products
Cepheid and bioMerieux Enter Into Strategic Agreements to Develop and Market Sepsis and MRSA Products
HSMN NewsFeed - 27 Sep 2006
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
Additional items found! 8
Members Archive contains
8 additional stories matching:
methicillin resistant Staphylococcus aureus
(Password required)
methicillin resistant Staphylococcus aureus
(Password required)
